C07K 16/243
Colony stimulating factors
Official title: {Colony Stimulating Factors}
C07K16/243 (Colony stimulating factors) appears on 181 US grants and 295 published applications in this corpus.
Search patents in C07K- Granted patents
- 181
- Published applications
- 295
- Assignees
- 125
- Inventors
- 499
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 2 | 0 |
| 1998 | 5 | 0 |
| 1999 | 5 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 4 |
| 2003 | 1 | 2 |
| 2004 | 1 | 4 |
| 2005 | 0 | 6 |
| 2006 | 2 | 8 |
| 2007 | 1 | 5 |
| 2008 | 4 | 15 |
| 2009 | 3 | 14 |
| 2010 | 7 | 14 |
| 2011 | 8 | 15 |
| 2012 | 8 | 12 |
| 2013 | 8 | 10 |
| 2014 | 6 | 17 |
| 2015 | 6 | 11 |
| 2016 | 20 | 20 |
| 2017 | 7 | 9 |
| 2018 | 11 | 15 |
| 2019 | 4 | 12 |
| 2020 | 8 | 15 |
| 2021 | 11 | 28 |
| 2022 | 8 | 14 |
| 2023 | 6 | 12 |
| 2024 | 6 | 13 |
| 2025 | 8 | 13 |
| 2026 | 4 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Use of M-CSF or G-CSF for diagnosis or treatment of pulmonary fibrosis1 Sep 2026US 12,723,073 B2Fnct Biotech, Inc.
- Materials and methods for treating cancer12 May 2026US 12,624,086 B2Mayo Foundation for Medical Education and Research
- Complex-specific antibodies and antibody fragments and its use31 Mar 2026US 12,590,172 B2Morphosys AG
- Splicing modulator antibody-drug conjugates and methods of use6 Jan 2026US 12,514,926 B2Eisai R&D Management Co., Ltd.
- Anti-G-CSF antibodies and uses thereof23 Sep 2025US 12,421,308 B2Me Therapeutics Inc.
- Splicing modulator antibody-drug conjugates and methods of use11 Jun 2026US 2026/0158152 A1Eisai R&D Management Co., Ltd.
- Combination treatment of chronic myelomonocytic leukemia in patients with ras pathway mutations11 Jun 2026US 2026/0159580 A1Taran Therapeutics, Inc.
- Macrophage depletion and vesicular stomatitis virus for treatment of cancer7 May 2026US 2026/0125459 A1Boehringer Ingelheim International GmbH
- Compositions of il-6/il-6r antibodies and methods of use thereof7 May 2026US 2026/0125483 A1Tiziana Life Sciences PLC
- Gene therapy30 Apr 2026US 2026/0115317 A1
Most cited
By later US patents
- Production of pluripotent granulocyte colony-stimulating factor304US 4,810,643 AKirin-Amgen, Inc. · 1989
- Hybridoma and monoclonal antibody for use in an immunoaffinity purification system210US 5,011,912 AImmunex Corporation · 1991
- Transgenic transchromosomal rodents for making human antibodies195US 7,041,870 B2Kirin Brewery Co., Ltd. · 2006
- Production of human pluripotent granulocyte colony-stimulating factor185US 4,999,291 AAmgen Inc. · 1991
- Human pluripotent granulocyte colony-stimulating factor152US 5,580,755 AAmgen Inc. · 1996